P

Inventor

KRAYNOV VADIM

US31 patents
⚠️ This page may combine multiple inventors who share the name “KRAYNOV VADIM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AMBRX INC

20 patents
US8012931B2Sep 6, 2011

Modified FGF-21 polypeptides and their uses

AMBRX INC76 citations98
US8383365B2Feb 26, 2013

Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine derivatives

AMBRX INC48 citations96
US10253083B2Apr 9, 2019

Therapeutic uses of modified relaxin polypeptides

AMBRX INC11 citations92
US9975936B2May 22, 2018

Nucleic acids encoding modified FGF-21 polypeptides comprising non-naturally occurring amino acids

AMBRX INC12 citations92
US9567386B2Feb 14, 2017

Therapeutic uses of modified relaxin polypeptides

AMBRX INC14 citations92
US9079971B2Jul 14, 2015

Modified FGF-21 polypeptides comprising non-naturally occurring amino acids

AMBRX INC19 citations92
US9517273B2Dec 13, 2016

Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acids

AMBRX INC15 citations91
US9452222B2Sep 27, 2016

Nucleic acids encoding modified relaxin polypeptides

AMBRX INC14 citations90
US10751391B2Aug 25, 2020

Methods of treatment using modified relaxin polypeptides comprising a non-naturally encoded amino acid

AMBRX INC6 citations83
US10702588B2Jul 7, 2020

Modified relaxin polypeptides comprising a non-naturally encoded amino acid in the A chain

AMBRX INC7 citations83
US9962450B2May 8, 2018

Method of treating heart failure with modified relaxin polypeptides

AMBRX INC9 citations83
US10961291B2Mar 30, 2021

Modified FGF-21 polypeptides and their uses

AMBRX INC1 citations72
US10377805B2Aug 13, 2019

Modified FGF-21 polypeptides comprising non-naturally encoding amino acids and their uses

AMBRX INC2 citations72
US10954270B2Mar 23, 2021

Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives

AMBRX INC2 citations69
US11993637B2May 28, 2024

Modified FGF-21 polypeptides with non-naturally encoded amino acids

AMBRX INC0 citations62
US11786578B2Oct 17, 2023

Modified relaxin polypeptides and their uses

AMBRX INC0 citations62
US11439710B2Sep 13, 2022

Nucleic acids encoding modified relaxin polypeptides

AMBRX INC0 citations62
US11311605B2Apr 26, 2022

Methods of treating heart failure and fibrotic disorders using modified relaxin polypeptides

AMBRX INC0 citations62
US11542310B2Jan 3, 2023

Modified bovine G-CSF polypeptides and their uses

AMBRX INC0 citations61
US11420999B2Aug 23, 2022

Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives

AMBRX INC0 citations59

KRAYNOV VADIM

4 patents

SCRIPPS RESEARCH INST

3 patents

MIAO ZHENWEI

2 patents

HAYS ANNA-MARIA A

1 patent

HAYS PUTNAM ANNA MARIA A

1 patent